Navigation Links
Three Nova Southeastern University researchers receive patents
Date:5/8/2014

FORT LAUDERDALE-DAVIE, Fla. Three Nova Southeastern University's (NSU) professors from three different colleges recently secured patents for their innovations.

"The idea of a university is to further innovation, promote scholarship and ultimately benefit humanity," said NSU President George L. Hanbury II, Ph.D. "Professors Rathinavelu, Thompson, and Harbaugh have developed new solutions to benefit the global community in their respective fields of pharmaceutical research, dentistry, and law, and I am proud to recognize them for their achievements."

Appu Rathinavelu, Ph.D., associate dean for institutional planning and development at NSU's College of Pharmacy, and executive director of NSU's Rumbaugh-Goodwin Institute for Cancer Research, received a Japanese patent for developing a novel cancer treatment. The small organic molecule called "JFD" that he and his team discovered is anti-angiogenic, meaning it "starves" tumors and other cancer cells by preventing blood flow that supplies the tumors with oxygen and nutrients that would otherwise help them to grow and survive. This molecule is less expensive to manufacture, stable in storage, expected to be less toxic, and is more effective against solid tumors. It is specifically designed to battle breast, ovarian, prostate, lung and colorectal cancers.

Jeffrey Thompson, Ph.D., professor of prosthodontics and director of the Biosciences Research Center in NSU's College of Dental Medicine, secured a U.S. patent for developing a surface modification technology to promote chemical bonding between high-performance ceramic materials like alumina and zirconia and biological materials, like tooth structures, and synthetic materials, like dentures and crowns. The research was conducted with a team of researchers from RTI International in Durham, N.C., and funded by a National Institute of Health (NIH)/National Institute of Dental and Craniofacial Research (NIDCR) grant.

Joseph Harbaugh, LL.M., professor of law and dean emeritus at NSU's Shepard Broad Law Center, has received a U.S. patent for developing a computer-based system called AAMPLE, the Alternative Admissions Model Program in Legal Education. The program reviews students' outcomes in a small number of classes to predict their likelihood of excelling in law school and passing the state bar exam. This differs from the widespread practice of heavily weighing students' LSAT scores and GPAs to determine admission to law school. AAMPLE is an alternate method to understand students' abilities to think critically and succeed in law school and as professionals.

"These three patents illustrate NSU's focus on developing novel, useful and relevant products and services to improve people's lives," said Gary S. Margules, Sc.D., NSU vice president for research and technology transfer.


'/>"/>

Contact: Jeremy Katzman, M.B.A.
j.katzman@nova.edu
954-262-5408
Nova Southeastern University
Source:Eurekalert  

Related medicine news :

1. Three Johns Hopkins faculty win Novo Nordisk awards for diabetes research
2. Three-quarters of people with seasonal and pandemic flu have no symptoms
3. Same cell death pathway involved in three forms of blindness, Penn team finds
4. Three Reasons Why Eye Contact Creates Better Sex
5. Foot Levelers to Honor Three at Parker Seminars Las Vegas
6. Natural Algae Astaxanthin Association Formed by Three Leading Astaxanthin Producers
7. Life Insurance No Medical Exam Plans Have Three Important Advantages For Seniors
8. Bioforce Announces Echinaforce® Named One of Three Top Supplements for Cold and Flu
9. MedMar Healing Center Co-founder Rafael Hernandez Goes the Distance for Leukemia and Lymphoma Society, Running Three Marathons for Nonprofit Health Organization
10. Antiperspirant for Hyperhidrosis, SweatBlock, Surpasses "Three Million Sold" Threshold
11. HUMAN Ranks #7 on Los Angeles Business Journal’s “Fastest Growing Private Companies” List with Three-Year Sales Growth of 514%
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Three Nova Southeastern University researchers receive patents
(Date:4/29/2016)... ... April 29, 2016 , ... For those who skip ... meal to miss. That was among the many new lifestyle diet tips offered by ... Sharon Kleyne Hour® Power of Water® radio show. Bonny and Lawrence noted that because ...
(Date:4/29/2016)... ... April 29, 2016 , ... Innovations with Ed Begley ... upcoming episode, airing third quarter 2016 via Discovery Channel. Dates and show times ... Dairy Products, located in Greenwood, Wisconsin applies product research and development and continuous ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... focused entirely on patients with cancer, today announced that Lynne Malestic, RN, of ... 2016 CURE® Extraordinary Healer® for Oncology Nursing , which honors nurses who ...
(Date:4/29/2016)... ... April 29, 2016 , ... Nike Softball Camp at ... from July 24th – 27th for girls aged 10-18. All facets of the game ... the beautiful Clark V. Whited Complex, one of the finest softball facilities in the ...
(Date:4/29/2016)... , ... April 29, 2016 , ... International Dehydrated Foods, ... on May 3 and 4 at the Doubletree by Hilton Hotel in Oak Brook, ... to marketing and applications technologies for protein ingredients. , At the seminar, IDF™ will ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016 Oramed ... a clinical-stage pharmaceutical company focused on the development of oral ... in the upcoming PIONEERS 2016 conference, presented by Joseph ... 2016 in New York . Nadav ... at the conference. Presentation Details:   ...
(Date:4/28/2016)... FREMONT, Calif. , April 28, 2016 ... Enterprise Validation Lifecycle Management Solutions (VLMS) today ... products and services for sufferers of chronic ... management System to manage their corporate validation ... been seeking a software solution to manage ...
(Date:4/28/2016)... , April 28, 2016 ... Review, H1 2016" is a report that provides ... helps strengthen R&D pipelines by identifying new targets ... Company Profiles discussed in this H1 ... Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen Pharma S.p.A., ...
Breaking Medicine Technology: